| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 05/07/2002 | US6383814 Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| 05/02/2002 | WO2001074840A3 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/02/2002 | WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 05/02/2002 | WO2001011068A3 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 04/25/2002 | WO2002032922A1 Process and intermediates for the production of 7-substituted antiestrogens |
| 04/24/2002 | EP0813684B1 Determination of steroids by competitive immunoassay |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |
| 04/23/2002 | US6376687 Steroid sulfatase inhibitors and methods for making and using the same |
| 04/18/2002 | US20020045774 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 04/18/2002 | US20020045746 Form L crystalline eplerenone having a monoclinic crystal system and an X-ray powder diffraction pattern with a peak at 8. 0+-0.2 degrees 2 theta . |
| 04/18/2002 | DE10048634A1 19-Nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21, 16alpha-Laktonring 19-Nor-17alpha-pregna-1,3,5 (10) triene-17beta-ols with a 21, 16alpha-lactone |
| 04/17/2002 | EP1196783A2 Screening for therapeutic agents being scap antagonists |
| 04/17/2002 | EP0970103B1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain |
| 04/11/2002 | WO2001045678A3 Medicament, a method for its production and the use thereof |
| 04/11/2002 | WO2001032680A3 18-nor-steroids as selectively active estrogens |
| 04/04/2002 | WO2002026763A1 19-NOR-17α-PREGNA-1,3,5 (10)-TRIEN-17β-OLS OF A 21,16α-LACTONE RING |
| 04/04/2002 | WO2001090137A3 NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11β-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17β-METHOXY-ESTRA-4,9-DIEN-3-ONE |
| 04/04/2002 | US20020040135 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them |
| 04/03/2002 | EP0986574B1 11beta-aryl substituted 14,17-ethano-oestratriens, method for the production of these compounds and their use in the production of medicaments. |
| 04/02/2002 | US6365582 S-substitute 11β-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
| 04/02/2002 | US6365579 Nitrate esters and their use for neurological conditions |
| 03/28/2002 | WO2002024627A1 Cationic lipids and use thereof |
| 03/28/2002 | WO2002000679A3 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 03/28/2002 | US20020038021 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 03/27/2002 | EP1189922A1 Steroid derivatives |
| 03/27/2002 | EP0792153B1 Compositions containing lazaroids and their use for preventing adhesions |
| 03/26/2002 | US6361791 Stable aqueous dispersions including cationic lipids |
| 03/20/2002 | EP1187846A2 11beta long-chain substituted estratrienes, method for their production, pharmaceutical preparations containing said 11beta long-chain substituted estratrienes, and their use for producing medicaments |
| 03/14/2002 | WO2002020510A1 Acid-sensitive compounds, preparation and uses thereof |
| 03/14/2002 | US20020032181 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/14/2002 | US20020032180 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/14/2002 | US20020032166 Biocompatible cationic detergents and uses therefor |
| 03/14/2002 | CA2421179A1 Acid-sensitive compounds, preparation and uses thereof |
| 03/13/2002 | EP1185674A1 Cationic lipids for gene transfer and preparation method thereof |
| 03/13/2002 | CN1340071A Double metal cyanide catalysts for producing polyether polyols |
| 03/13/2002 | CN1340056A Steroides sulfatase inhibitors and methods for making and using same |
| 03/06/2002 | CN1080267C Preparation of intermediat of 19, 11 beta-bridge steroid |
| 03/05/2002 | US6352980 Estrenes for inducting hypothalamic effects |
| 02/28/2002 | WO2002016394A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds |
| 02/28/2002 | WO2002016393A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016392A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | US20020025951 Urogenital disorders |
| 02/27/2002 | EP0970105B1 Process for preparing carboxamido-4-azasteroids |
| 02/26/2002 | US6350738 Gramnegative bactericides; fungicides, viricides; gonane derivatives with nitrogen-containing substituent(s) |
| 02/21/2002 | WO2002014342A1 Steroid derived antibiotics |
| 02/14/2002 | WO2002012267A1 Method for the production of fluorescein bile acid derivatives |
| 02/14/2002 | WO2001076531A3 Bile acid containing prodrugs with enhanced bioavailability |
| 02/14/2002 | US20020019549 Reduction; chelation |
| 02/14/2002 | US20020019376 Steroid derived antibiotics |
| 02/13/2002 | EP1179005A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 02/07/2002 | US20020016311 Nitrate esters and their use for neurological conditions |
| 01/31/2002 | WO2002007771A1 Pharmaceutically active compound |
| 01/31/2002 | US20020013302 Sterol derivative compounds, structurally related to natural compounds which can be extracted from bull testes and from human follicular fluid, for regulating meiosis in oocytes and in male germ cells; use in treating infertility, |
| 01/31/2002 | US20020013282 Transfecting a cell comprising by contacting the cell with a biologically active nucleic acid molecule in the presence of a cationic lipid which can be protonated; cationic amphiphiles to transport drugs into cells; gene therapy |
| 01/31/2002 | CA2416608A1 Pharmaceutically active compound |
| 01/29/2002 | US6342598 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| 01/29/2002 | US6342489 Treatment of iron deficiency with ferric salt of bis hemisuccinylursodeoxycholic acid |
| 01/24/2002 | WO2002006299A2 Therapeutic uses for aminosterol compounds |
| 01/17/2002 | WO2002004410A1 Process for producing sulfamate compound |
| 01/17/2002 | US20020007073 Capable of producing complexes with polynucleotides (DNA, RNA, antisense oligonucleotides, ribozymes); suitable as vectors for transfection |
| 01/15/2002 | US6339079 Steroid sulfamates, method for the production and use thereof |
| 01/15/2002 | US6339077 Substituted 4-benzylaminoquinolines and their hetero analogs, process for their preparation, pharmaceuticals containing these compounds and use thereof |
| 01/10/2002 | WO2002002589A1 Novel antiandrogenic agent |
| 01/10/2002 | US20020004202 In vivo screen using chemical inducers of dimerization |
| 01/09/2002 | EP1169337A2 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |
| 01/03/2002 | WO2002000680A2 Cationic steroid derivatives for gene delivery |
| 01/03/2002 | WO2002000679A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/03/2002 | US20020002294 Antitumor agents |
| 01/03/2002 | US20020002155 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 01/02/2002 | EP1165657A1 Double metal cyanide catalysts for producing polyether polyols |
| 01/02/2002 | EP1165595A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486 |
| 12/27/2001 | US20010056182 Process for the preparation of (E,Z) 3-(2-aminoethoxyimino)-androstane-6,17-dione and its analogues |
| 12/19/2001 | EP1163258A1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis |
| 12/19/2001 | EP1163029A2 Nitrate esters and their use for inducing neuroprotection and cognition enhancement |
| 12/19/2001 | EP1162977A1 (androst-5-en-17beta-yl)alkyl sulfoxides and sulfones and their use for the control of fertility |
| 12/18/2001 | US6331534 Steroids as neurochemical stimulators of the VNO to alleviate pain |
| 12/18/2001 | US6331524 Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy |
| 12/13/2001 | WO2001093918A2 Radioimaging probes and the use thereof |
| 12/13/2001 | WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters |
| 12/13/2001 | DE10028193A1 New bile acid conjugates with benzylamino substituted aromatic and heteroaromatic compounds useful for prevention and treatment of gall stones |
| 12/13/2001 | DE10027887A1 Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Compounds having a sulfonamide group, these compounds and pharmaceutical compositions containing them |
| 12/13/2001 | CA2411586A1 Radioimaging probes and the use thereof |
| 12/12/2001 | CN1326461A Meiosis regulating compounds |
| 12/06/2001 | WO2001091797A2 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 12/06/2001 | CA2410630A1 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 12/05/2001 | EP0749437B1 Pharmaceutical uses of steroid derivatives |
| 12/05/2001 | CN1325403A Bile-acid substituted phenyl-alkenoylguanidines, method for the production thereof, use thereof as medicaments or diaymostic agents and medicaments that contain |
| 12/05/2001 | CN1324802A Anti-pregnancy hormone active steroid with fluorated 17 alpha-alkyl-chain |
| 11/29/2001 | WO2001090137A2 NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11β-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17β-METHOXY-ESTRA-4,9-DIEN-3-ONE |
| 11/28/2001 | EP1157996A1 New solid forms of mesoprogestin 11beta-(4E-(hydroxyiminomethyl)-phenyl)-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on |
| 11/28/2001 | EP1157028A1 Novel substituted 11.beta steroid derivatives, method for preparing same and intermediates of said method, use as medicine and compositions containing them |
| 11/28/2001 | EP0906332B1 7alpha-(5-methylaminopentyl)-estratrienes, process for the preparation thereof, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl)-estratrienes and use thereof for production of drugs |
| 11/27/2001 | US6323234 Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity |
| 11/27/2001 | CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
| 11/21/2001 | EP1156058A2 Process for the preparation of (E,Z) 3-(2-aminoethoxyimino)-androstane-6,17-dione and its analogues |
| 11/20/2001 | US6319516 Lipophilic group, linker bond, spacer arm and a cationic amino group; stability; |
| 11/15/2001 | WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| 11/15/2001 | CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |